This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. [Review] Curr. Top. Microbiol. Immunol. 158, 97–129 (1992).
Samulski, R.J. Adeno-associated virus-based vectors for human gene therapy. in Gene Therapy from Laboratory to the Clinic (ed. Hui, K.M.) 232–271 (World Scientific, Singapore, 1994).
Flotte, T.R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613–10617 (1993).
Monahan, P.E. et al. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. (in the press).
Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082–14087 (1996).
Xiao, X. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8090–8108 (1996).
Kaplitt, M.G. et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148–154 (1994).
Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270–276 (1997).
Xiao, X., Li, J., McCown, T.J. & Samulski, R.J. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp. Neural. 144, 113–124 (1997).
Samulski, R.J., Chang, L.S. & Shenk, T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096–3101 (1987).
Samulski, R.J., Chang, L.S. & Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822–3828 (1989).
Clark, K.R., Voulgaropoulou, F., Fraley, D.M. & Johnson, P.R. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329–1341 (1995).
Flotte, T.R. et al. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2, 29–37 (1995).
Vincent, K.A., Piraino, S.T. & Wadsworth, S.C. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71, 1897–1905 (1997).
Li, J., Samulski, R.J. & Xiao, X. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236–5243 (1997).
Carter, B.J. Adeno-associated virus helper functions. in CRC Handbook of Parvoviruses 1 (ed. Tijssen, P.) 255–282 (CRC Press, Boca Raton, Florida, 1990).
McCoy, R.D. et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1553–1560 (1995).
Ferrari, F.K., Samulski, T., Shenk, T. & Samulski, R.J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227–3234 (1996).
Snyder, R.O., Xiao, X. & Samulski, R.J. Production of recombinant adeno-associated viral vectors. in Current Protocols in Human Genetics (eds. Dracopoli, N. et al.) (John Wiley, New York, 1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrari, F., Xiao, X., Mccarty, D. et al. New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med 3, 1295–1297 (1997). https://doi.org/10.1038/nm1197-1295
Issue Date:
DOI: https://doi.org/10.1038/nm1197-1295
This article is cited by
-
Characterization of Genome Integrity for Oversized Recombinant AAV Vector
Molecular Therapy (2010)
-
Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival
Gene Therapy (2004)
-
Receptor targeting of adeno-associated virus vectors
Gene Therapy (2003)
-
Replication competent helper functions for recombinant AAV vector generation
Gene Therapy (2002)
-
Adeno-Associated Virus —Mediated Gene Transfer for Hemophilia B
International Journal of Hematology (2002)